K.U.Leuven Research&Development

USPTO Trademark & Patent Filings

K U Leuven Research Development

Trademark applications and grants for K.u.leuven Research&development. K.u.leuven Research&development has 9 trademark applications. The latest application filed is for "OKAPI SCIENCES - ANTIVIRALS FOR ANIMALS"

Company Profile
    Company Aliases
  • K.U.Leuven Research & Development
  • K.U.Leuven Research and Development
  • K.U.Leuven Research&Development
  • development research leuven u k
  • K.U. LEUVEN RESEARCH & DEVELOPMENT - Leuven BE
  • K.U. LEUVEN RESEARCH AND DEVELOPMENT - LEUVEN BE
  • K.U. LEUVEN RESEARCH & DEVELOPMENT - LEUVEN BE
  • K.U. Leuven Research & Development - Leuven BE
State Incorporated BELGIUM
Entity Type University
Address 8A Minderbroedersstraat Leuven BELGIUM 3000

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION
20160009750 - 14/867208 HERDEWIJN; Piet ;   et al.
2016-01-14
ANTI-VIRAL PYRIMIDINE NUCLEOSIDE DERIVATIVES
20150072948 - 14/482125 McGuigan; Christopher ;   et al.
2015-03-12
PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION
20140316127 - 14/317448 HERDEWIJN; Piet ;   et al.
2014-10-23
INTEGRASE COFACTOR
20140128316 - 14/030030 DEBYSER; Zeger ;   et al.
2014-05-08
PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION
20140039179 - 13/940039 HERDEWIJN; Piet ;   et al.
2014-02-06
Yeast alleles involved in tolerance to high alcohol levels
11,174,497 - 15/754,524 Verstrepen , et al. November 16, 2
2021-11-16
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
9,522,932 - 14/867,208 Herdewijn , et al. December 20, 2
2016-12-20
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
9,522,932 - 14/867,208 Herdewijn , et al. December 20, 2
2016-12-20
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
9,249,177 - 14/317,448 Herdewijn , et al. February 2, 2
2016-02-02
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
9,249,177 - 14/317,448 Herdewijn , et al. February 2, 2
2016-02-02
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed